Analyzing the Scope and Claims of United States Patent 5,002,769
Introduction
United States Patent 5,002,769, titled "Cross-Linked Protein Matrix and Its Use for the Controlled Release of Biologically Active Agents," is a patent that has significant implications in the field of biomedical engineering and pharmaceuticals. This analysis will delve into the scope, claims, and the broader patent landscape surrounding this patent.
Patent Overview
The patent, issued on March 26, 1991, describes a cross-linked protein matrix designed for the controlled release of biologically active agents. This technology is crucial in the development of drug delivery systems, particularly for medications that require sustained release over a period of time.
Claims Analysis
Independent Claims
The patent includes several independent claims that define the scope of the invention. Here are some key points:
-
Claim 1: This claim describes the cross-linked protein matrix itself, specifying the types of proteins and cross-linking agents used. It sets the foundation for the subsequent claims by defining the core structure of the matrix[4].
-
Claim 2: This claim focuses on the method of preparing the cross-linked protein matrix. It outlines the steps involved in creating the matrix, including the mixing of proteins and cross-linking agents, and the conditions under which the cross-linking reaction occurs[4].
-
Claim 3: This claim pertains to the use of the cross-linked protein matrix for the controlled release of biologically active agents. It specifies the types of agents that can be released and the conditions under which the release occurs[4].
Dependent Claims
Dependent claims further narrow down the scope of the independent claims by adding additional limitations. For example:
-
Claim 4: This claim depends on Claim 1 and specifies particular types of proteins that can be used in the matrix, such as collagen or gelatin[4].
-
Claim 5: This claim depends on Claim 2 and details specific cross-linking agents, such as glutaraldehyde or formaldehyde[4].
Scope of the Patent
The scope of the patent is defined by the claims and the description provided in the specification.
Structural and Functional Features
The patent claims are structured to include both structural and functional features. For instance, Claim 1 describes the structural composition of the cross-linked protein matrix, while Claim 3 describes the functional aspect of using this matrix for controlled release. This dual approach ensures that the patent covers both the physical characteristics and the intended use of the invention[2].
Novelty and Non-Obviousness
The patent's validity hinges on its novelty and non-obviousness. The examiner's review, as seen in the patent file wrapper, would have involved assessing whether the claims overcome prior art. Any cited prior art, such as U.S. Pat. No. 5,002,769, would have been scrutinized to determine if the current invention is novel and non-obvious in light of existing technologies[1].
Patent Landscape
Prior Art and Cited References
The patent landscape surrounding U.S. Patent 5,002,769 includes various prior art references that were considered during the examination process. For example, similar materials using cross-linked protein matrices for active agent delivery were described in other patents, such as those mentioned in the patent application itself[4].
Competitors and Related Patents
Other patents in the field of drug delivery systems using protein matrices would be part of the competitive landscape. Companies and researchers working on similar technologies would need to ensure their inventions do not infringe on the claims of U.S. Patent 5,002,769. This involves a detailed analysis of the patent's claims and the prior art cited during its prosecution[1].
Competitive Intelligence
Using Patent File Wrappers
Patent file wrappers, or prosecution histories, are invaluable for competitive intelligence. They provide insights into the arguments made between the patent applicant and the examiner, including any rejections, amendments, and notices of allowance. For U.S. Patent 5,002,769, analyzing the file wrapper could reveal:
-
Cited Prior Art: Understanding which prior art was cited against the patent and how the applicant overcame these citations can provide valuable insights into the patent's uniqueness and the broader technological landscape[1].
-
Examiner's Arguments: The examiner's rejections and the applicant's responses can highlight the critical features of the invention and why they were deemed novel and non-obvious[1].
Legal and Regulatory Implications
Patent Expiration and Exclusivity
The patent's expiration date is crucial for understanding when the technology will enter the public domain. For pharmaceuticals, this can also involve exclusivity periods and regulatory approvals. For instance, changes in patent regulations, such as those brought about by the Uruguay Round Agreements Act (URAA), can affect the patent term and exclusivity periods[5].
Industry Impact
Innovation and Licensing
The patent's scope and claims can significantly impact innovation in the field. Broad or unclear claims can lead to increased licensing and litigation costs, potentially stifling innovation. Conversely, well-defined claims can provide clear boundaries, encouraging further research and development[3].
Market Dominance
Companies holding patents like U.S. Patent 5,002,769 can leverage this intellectual property to gain market dominance. By understanding the competitive landscape and the unique features of their patent, companies can make strategic decisions regarding licensing, partnerships, and product development.
Key Takeaways
- Detailed Claims Analysis: The patent's claims define its scope and are crucial for understanding its novelty and non-obviousness.
- Patent Landscape: Analyzing prior art and related patents is essential for navigating the competitive landscape.
- Competitive Intelligence: Patent file wrappers provide valuable insights into the patent's prosecution history and its uniqueness.
- Legal and Regulatory Implications: Understanding patent expiration dates and exclusivity periods is vital for strategic planning.
- Industry Impact: Well-defined claims can foster innovation and market dominance.
FAQs
Q1: What is the main subject of U.S. Patent 5,002,769?
A1: The main subject is a cross-linked protein matrix for the controlled release of biologically active agents.
Q2: How can one analyze the scope of this patent?
A2: By examining the independent and dependent claims, as well as the description provided in the specification.
Q3: What is the significance of the patent file wrapper in competitive intelligence?
A3: The patent file wrapper provides detailed insights into the arguments between the applicant and the examiner, including cited prior art and rejections.
Q4: How does the patent's expiration date affect its market impact?
A4: The expiration date determines when the technology enters the public domain, affecting licensing, exclusivity periods, and market competition.
Q5: Why are clear and well-defined claims important for innovation?
A5: Clear claims provide clear boundaries, reducing licensing and litigation costs and encouraging further research and development.
Sources
- IP Checkups - Patent file wrappers as a tool for competitive intelligence
- BIPC - Federal Circuit Finds Claim Reciting Both Apparatus and Process Limitations May Be Definite
- Hoover Institution - Patent Claims and Patent Scope
- Google Patents - US20070238797A1 - Medicated Polyurethane Foams
- FOI Services - Patent Drugs Under Patent
